Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and toxicity of
docetaxel/cisplatin/5-fluorouracil induction chemotherapy (4 cycles) followed by concomitant
chemoradiation with cetuximab and weekly cisplatin in patients with inoperable squamous cell
carcinoma of the head and neck.